ArticleEndocrine connections2026

Projected life-year gains with semaglutide in individuals with cardiovascular disease without type 2 diabetes in the UK.

Thomas Van Sloten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.